IGF2BP3 and nasopharyngeal carcinoma: An in vitro study of nasopharyngeal carcinoma showed that IGF2BP3 regulates key EMT regulatory factors by activating the AKT/mTOR signalling pathway, thus promoting the migration and invasion of nasopharyngeal carcinoma cells.11